Retrospective study analyzes survival benefits of adjuvant chemotherapy in older patients, suggesting risk stratification for treatment decisions.
Adjuvant chemotherapy provides significant survival benefits in older patients with high-risk stage III, but not high-risk stage II or low-risk stage III, colon cancer. Risk stratification, rather than age, should guide treatment decisions.
No takes yet. Share an insight, caveat, or question.
Bae et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: